InnoCare Pharma Ltd
HKEX:9969
InnoCare Pharma Ltd
Interest Income Expense
InnoCare Pharma Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
InnoCare Pharma Ltd
HKEX:9969
|
Interest Income Expense
-¥162.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Interest Income Expense
-¥59.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Interest Income Expense
¥445.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
84%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Interest Income Expense
¥217.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
134%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Interest Income Expense
-¥33.6m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Interest Income Expense
¥100.8m
|
CAGR 3-Years
126%
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
See Also
What is InnoCare Pharma Ltd's Interest Income Expense?
Interest Income Expense
-162.3m
CNY
Based on the financial report for Dec 31, 2022, InnoCare Pharma Ltd's Interest Income Expense amounts to -162.3m CNY.